Hamilton Pharmaceuticals Overview
- Year Founded
-
2004
- Status
-
Acquired/Merged
- Latest Deal Type
-
M&A
- Latest Deal Amount
-
$3.16M
Hamilton Pharmaceuticals General Information
Description
Developer of medical treatments for diseases related to central nervous system. The company engages in the development of late-stage products for neurology and psychiatry.
Contact Information
Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Primary Office
- 1825 K Street Northwest
- Suite 520
- Washington, DC 20006
- United States
Hamilton Pharmaceuticals Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Merger/Acquisition | 15-Oct-2007 | $3.16M | 0000 | 00.000 | Completed | Generating Revenue |
| 2. Early Stage VC (Series A) | 22-Apr-2005 | 0000 | 0000 | Completed | Generating Revenue | |
| 1. Early Stage VC | 01-Oct-2004 | Completed | Startup |
Hamilton Pharmaceuticals Patents
Hamilton Pharmaceuticals Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20040063776-A1 | 2-oxo-1-pyrrolidineacetamide derivatives are useful for treating cancer pain and other neuropathic pain | Active | 28-Dec-2000 | 00000000000 | |
| US-7608636-B2 | 2-oxo-1-pyrrolidineacetamide derivatives are useful for treating cancer pain and other neuropathic pain | Inactive | 28-Dec-2000 | 00000000000 | |
| CA-2433039-A1 | Agent for therapeutic and prophylactic treatment of neuropathic pain | Active | 28-Dec-2000 | 00000000000 | |
| CA-2433039-C | Agent for therapeutic and prophylactic treatment of neuropathic pain | Inactive | 28-Dec-2000 | 00000000000 | |
| DE-60138733-D1 | Medicament for treatment and prevention of neurogenic pain | Inactive | 28-Dec-2000 | C07D207/263 |
Hamilton Pharmaceuticals Former Investors (3)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|---|---|---|---|---|
| CNF Investments | PE/Buyout | Minority | 000 0000 | 000000 0 | |
| Index Ventures | Venture Capital | Minority | 000 0000 | 000000 0 | |
| Vivo Capital | Venture Capital | Minority | 000 0000 | 000000 0 |